Senores Pharmaceuticals announced that it has received final approval from the United States Food and Drug Administration (USFDA) to market Metoprolol Tartrate and Hydrochlorothiazide Tablet USP, 50 ...

Shares of Senores Pharmaceuticals Ltd on Monday listed with a premium of over 53 per cent against the issue price of Rs 391. The stock made its debut at Rs 593.70, rallying 51.84 per cent from the ...

Senores Pharmaceuticals shares debuted strongly on the NSE today, listing at Rs 600 per share, a premium of over 53 per cent ...

Shares of three companies namely- Senores Pharmaceuticals, Ventive Hospitality and Carrora India- made their Dalal Street ...

Senores Pharmaceuticals IPO Allotment Status: The allotment of the Senores Pharmaceuticals IPO has been finalised. The initial public offering of Senores Pharmaceuticals Ltd closed on Tuesday and ...

Retail Individual Investors (RIIs) subscribed to their reserved portion 90.46 times. Established in 2017, Senores Pharmaceuticals is a research-driven company specialising in developing and ...

Senores Pharmaceuticals IPO Allotment Today: At the upper price band, the company is valued at a P/E of 55x with a market cap of Rs 1800.6 crore (Image: Freepik) The allotment of Senores ...

Senores Pharmaceuticals IPO allotment status: Investors can check their allotment by visiting the websites of the Bombay Stock Exchange (BSE) or Link Intime India. Listen to Story Senores Pharma IPO ...

Senores Pharmaceuticals IPO share allotment will be finalized soon, with investors able to check their status via BSE or the registrar's website. The IPO saw a robust subscription of over 93.41 times, ...

After finalising the share allotment status, the company will initiate refunds and transfer of shares to the demat accounts on Friday, December 27. Senores Pharmaceuticals Ltd is expected to finalise ...